Doi.org/10.1016/j.radonc.2012.08.022
Revision as of 05:49, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy.; Zhang, An-Mei, et al.; Radiotherapy and Oncology; 2012; https://doi.org/10.1016/j.radonc.2012.08.022 == Article providing comments == Reply to Tamojit Chaudhuri et al. “Comment on: Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasophary...")
Target Article[edit | edit source]
Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy.; Zhang, An-Mei, et al.; Radiotherapy and Oncology; 2012; https://doi.org/10.1016/j.radonc.2012.08.022
Article providing comments[edit | edit source]
Reply to Tamojit Chaudhuri et al. “Comment on: Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy”; Zhang, An-Mei; Chen, Zheng-Tang; Fan, Ye; ; Radiotherapy and Oncology; 2013-3-01 https://doi.org/10.1016/j.radonc.2013.02.011
Summary[edit | edit source]
Note: Opened to append information.